J. A. Avina-zubieta, J. Thomas, M. Sadatsafavi, A. J. Lehman, and D. Lacaille, Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies, Ann Rheum Dis, vol.71, issue.9, pp.1524-1533, 2012.

C. S. Crowson, E. L. Matteson, V. L. Roger, T. M. Therneau, and S. E. Gabriel, Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis, Am J Cardiol, vol.110, issue.3, pp.420-424, 2012.

J. Sokolove, R. Bromberg, K. D. Deane, L. J. Lahey, L. A. Derber et al., Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis, PLoS One, vol.7, issue.5, p.35296, 2012.

M. Brink, M. Hansson, L. Mathsson-alm, P. Wijayatunga, M. K. Verheul et al., Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis, Arthritis Res Ther, vol.18, p.43, 2016.

R. Raijmakers, J. J. Van-beers, M. El-azzouny, N. F. Visser, B. Bozic et al., Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients, Arthritis Res Ther, vol.14, issue.3, p.114, 2012.

J. Sokolove, M. J. Brennan, O. Sharpe, L. J. Lahey, A. H. Kao et al., Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis, Arthritis Rheum, vol.65, issue.7, pp.1719-1743, 2013.

A. Montes, A. Corrales, M. Calaza, R. Lopez-mejias, J. A. Parra et al., Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis, Arthritis Rheumatol, vol.67, issue.11, pp.2861-2866, 2015.

J. M. Kollman, L. Pandi, M. R. Sawaya, M. Riley, and R. F. Doolittle, Crystal structure of human fibrinogen, Biochemistry, vol.48, issue.18, pp.3877-86, 2009.

K. P. Liao, T. Cai, V. Gainer, S. Goryachev, Q. Zeng-treitler et al., Electronic medical records for discovery research in rheumatoid arthritis, Arthritis Care Res (Hoboken), vol.62, issue.8, pp.1120-1127, 2010.

F. Kurreeman, K. Liao, L. Chibnik, B. Hickey, E. Stahl et al., Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records, Am J Hum Genet, vol.88, issue.1, pp.57-69, 2010.

K. P. Liao, A. N. Ananthakrishnan, V. Kumar, Z. Xia, A. Cagan et al., Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts, PLoS One, vol.10, issue.8, p.136651, 2015.

J. C. Denny, L. Bastarache, M. D. Ritchie, R. J. Carroll, R. Zink et al., Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data, Nat Biotechnol, vol.31, issue.12, pp.1102-1112, 2013.

R. S. Vasan, Biomarkers of cardiovascular disease: molecular basis and practical considerations, Circulation, vol.113, pp.2335-62, 2006.

K. P. Liao, J. A. Sparks, B. P. Hejblum, I. H. Kuo, J. Cui et al., Phenome-Wide Association Study of Autoantibodies to Citrullinated and Noncitrullinated Epitopes in Rheumatoid Arthritis, Arthritis Rheumatol, vol.69, issue.4, pp.742-749, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01654405

C. Fernandes-cerqueira, E. Ossipova, S. Gunasekera, M. Hansson, L. Mathsson et al., Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens, Arthritis Res Ther, vol.17, p.155, 2015.

E. B. Smith and . Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis, Clin Haematol, vol.15, issue.2, pp.355-70, 1986.

, Clinical characteristics of cohort (n=1006), vol.1

D. ,

D. Biologic,

. Non-biologic and . Dmard,

, TNFi Smoking, ever, n (%)

. Prednisone,